Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Pharmacology

• Publication date

  2001-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0704248PMID 11564653PMCID PMC1572950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.

  2003influential reference
• A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.

  2000cited by this paper
• On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.

  2000cited by this paper
• Combination therapy with clopidogrel and aspirin after coronary stenting

  2000cited by this paper
• A Whole Blood Assay of Inhibition of Platelet Aggregation by Glycoprotein IIb/IIIa Antagonists: Comparison with other Aggregation Methodologies

  1999cited by this paper
• Platelets and stroke

  1999cited by this paper
• Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study

  1999cited by this paper
• Role of Intracellular Signaling Events in ADP-induced Platelet Aggregation

  1999cited by this paper
• Recent Advances in Platelet-Polymorphonuclear Leukocyte Interaction

  1999cited by this paper
• The relationship between mean platelet volume, stroke subtype and clinical outcome.

  1998cited by this paper
• Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood.

  1998cited by this paper
• Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.

  1998cited by this paper
• Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty.

  1997cited by this paper
• Changes in plasma ionised calcium within 24 hours of trauma in patients infused with the calcium containing colloid Haemaccel during fluid resuscitation.

  1997cited by this paper
• Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium.

  1996cited by this paper
• Increased neutrophil-platelet adhesion in patients with unstable angina.

  1996cited by this paper
• European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

  1996cited by this paper
• Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass.

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation.

  1991influential reference
• Stratton lecture 1989. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism.

  1990influential reference
• Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents.

  1989cited by this paper
• Dipyridamole.

  1987cited by this paper
• Drug therapy. Dipyrimadole

  1987cited by this paper
• Platelet Aggregation in Whole Blood Determined Using the Ultra-Flo 100 Platelet Counter

  1982influential reference

• 1,8-Cineole inhibits platelet-leukocyte aggregate formation by reducing P-selectin expression

  2025cites this paper
• The effectiveness and safety of administering antiplatelet medications following reperfusion therapy in patients with ischemic stroke

  2025cites this paper
• Platelet-leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential.

  2025cites this paper
• Improving the Quality of EDTA-treated Blood Specimens from Mice.

  2022cites this paper
• Platelet–Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases

  2022cites this paper
• Heightened Procoagulation after Post-Operative Thromboprophylaxis Completion in Patients with Metastatic Bone Disease from Primary Colorectal Cancer

  2022cites this paper
• Ticagrelor: clinical development and future potential.

  2021cites this paper
• Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

  2020cites this paper
• A meta-analysis on anticoagulation after vascular trauma

  2020cites this paper
• The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study

  2018cites this paper
• Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.

  2018cites this paper
• Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.

  2018cites this paper
• Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)

  2018cites this paper
• P2Y12-dependent modulation of ADP-evoked calcium responses in human monocytes

  2018cites this paper
• Baseline characteristics of the 3096 patients recruited into the ‘Triple Antiplatelets for Reducing Dependency after Ischemic Stroke’ trial

  2017cites this paper
• Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)

  2015cites this paper
• Future Perspectives in Stroke Management

  2015cites this paper
• A review on the requirements of modelling of blood flow

  2015cites this paper
• TRIAL / STUDY PERSONNEL AND CONTACT DETAILS

  2014cites this paper
• Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial

  2014cites this paper
• Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry?

  2013cites this paper
• BF066, a Novel Dual Target Antiplatelet Agent without Significant Bleeding

  2012cites this paper
• Effects of FEIBA on platelet and leucocyte activation in severe haemophilia patients with inhibitors

  2012cites this paper
• Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y12 Antagonist

  2011cites this paper
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase

  2011cites this paper
• Hemoptysis under Diclofenac and Antiplatelet Doses of Aspirin

  2010cites this paper
• EFFECT OF ASPIRIN ON HEMOSTASIS: SYNERGISM OR ANTAGONISM WITH NON STEROIDAL ANTI-INFLAMMATORY AGENTS

  2010cites this paper
• Inflammation and cortisol response in coronary artery disease

  2009cites this paper
• Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

  2009cites this paper
• Effect of Clopidogrel on Adhesion Molecules, Hemostasis, and Fibrinolysis in Coronary Heart Disease

  2008cites this paper
• A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility

  2008cites this paper
• Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents

  2008cites this paper
• Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.

  2008cites this paper
• Inhibition of platelet aggregation with combination of antiplatelet agents

  2008cites this paper
• TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents

  2007influential citation
• Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan

  2007cites this paper
• TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents.

  2007cites this paper
• Aspirin and Clopidogrel Resistance in Drug Eluting Stent Era

  2007cites this paper
• CHAPTER 37 – Peripheral Vascular Disease

  2007cites this paper
• POINT OF CARE TESTING OF ASPIRIN RESISTANCE IN PATIENTS WITH VASCULAR DISEASE

  2006cites this paper
• Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke

  2006cites this paper
• Aspirin resistance or variable response or both?

  2006cites this paper
• Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.

  2005cites this paper
• FarmacologÌa de los agentes antiagregantes plaquetarios

  2005cites this paper
• Prevalence, profile, predictors, and natural history of aspirin resistance measured by the ultegra rapid platelet function assay- asain patients with coronary artery disease

  2005cites this paper
• Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke

  2005cites this paper
• Assessment of platelet activation and function in ischaemic stroke, transient ischaemic attack and asymptomatic severe caratid stenosis.

  2004cites this paper
• Antithrombotic therapy for prevention of recurrent stroke in the new millenium

  2004cites this paper
• Central role of the P2Y12 receptor in platelet activation.

  2004cites this paper
• Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke

  2004cites this paper
• Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke.

  2004cites this paper
• Statin Reduce the Platelet P-Selectin Expression in Atherosclerotic Ischemic Stroke

  2004cites this paper
• Aspirin resistance in cardiovascular disease: a review.

  2004cites this paper
• Platelets activation in patients undergoing PTCA and their responsiveness after in vitro stimulation.

  2003cites this paper
• Potential Value of Triple Antiplatelet Therapy for Secondary Stroke Prevention

  2003cites this paper
• ADP receptors--targets for developing antithrombotic agents.

  2003cites this paper
• The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions

  2003cites this paper
• Role of Oral Blockade of Platelet Glycoprotein IIb/IIIa on Neutrophil Activation in Patients with Acute Coronary Syndromes

  2003cites this paper
• Potential value of triple antiplatelet therapy for secondary stroke prevention.

  2003cites this paper